+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review

Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Terumo Corp (Terumo) is a medical technology company. Its primary activities include the manufacture and sales of medical products and equipment, with a focus on vascular intervention, cardio-surgical solutions, blood transfusion and cell therapy technology, and daily clinical practice essentials. Terumo's product portfolio includes pharmaceuticals, blood bags, disposable medical devices, cardiovascular systems, vascular grafts, peritoneal dialysis, blood glucose monitoring systems, medical electronics, and digital thermometers. The company operates through several divisions, including Terumo Interventional Systems, MicroVention, Terumo Cardiovascular, and Terumo Aortic. Terumo's products are used by medical professionals in various healthcare settings, with applications ranging from cardiac surgery to diabetes care. The company operates through subsidiaries and associate companies in Europe, North America, South America, Asia Pacific, the Middle East, and Africa. Terumo is headquartered in Shibuya-ku, Tokyo, Japan

Terumo Corp Key Recent Developments

  • Aug 10, 2026: Q&A From Terumo Financial Results Briefing for the First Quarter of Fiscal 2027
  • Aug 07, 2026: Terumo Revises Full-Year Consolidated Financial Results Forecast for Fiscal Year Ending March 2027
  • Mar 19, 2026: Tata Elxsi Launches Global Offshore Development Center for Terumo Corporation
  • Mar 19, 2026: Tata Elxsi Opens Offshore Development Center for Terumo Corporation

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Terumo Corp - Key Facts
  • Terumo Corp - Key Employees
  • Terumo Corp - Key Employee Biographies
  • Terumo Corp - Major Products and Services
  • Terumo Corp - History
  • Terumo Corp - Company Statement
  • Terumo Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Terumo Corp - Business Description
  • Business Segment: Blood and Cell Technologies Company
  • Overview
  • Performance
  • Business Segment: Cardiac and Vascular Company
  • Overview
  • Performance
  • Business Segment: Medical Care Solutions Company
  • Overview
  • Performance
  • Business Segment: Organ Technologies
  • Performance
  • Geographical Segment: Americas
  • Performance
  • Performance
  • Geographical Segment: China
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Japan
  • Performance
  • Geographical Segment: Overseas
  • Performance
  • R&D Overview
  • Terumo Corp - Corporate Strategy
  • Terumo Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Terumo Corp - Strengths
  • Terumo Corp - Weaknesses
  • Terumo Corp - Opportunities
  • Terumo Corp - Threats
  • Terumo Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Terumo Corp, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • Terumo Corp, Medical Equipment, Deals By Type, 2020 to YTD 2026
  • Terumo Corp, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Aug 10, 2026: Q&A From Terumo Financial Results Briefing for the First Quarter of Fiscal 2027
  • Aug 07, 2026: Terumo Revises Full-Year Consolidated Financial Results Forecast for Fiscal Year Ending March 2027
  • Mar 19, 2026: Tata Elxsi Launches Global Offshore Development Center for Terumo Corporation
  • Mar 19, 2026: Tata Elxsi Opens Offshore Development Center for Terumo Corporation
  • Aug 25, 2025: OrganOx Achieves One of the UK’s Largest Medtech Exit To Date, Generating Record Returns for BGF
  • Feb 27, 2025: Terumo and Daiichi Sankyo Partner to Support Cardiovascular Care in Vietnam
  • Jan 15, 2025: Terumo Launches its Injection Filter Needle, a First Step of the INFINO -Development Program, to Extend the Choice for Hypodermic and Intravitreal Injections
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact Us
  • Disclaimer
List of Tables
  • Terumo Corp, Key Facts
  • Terumo Corp, Key Employees
  • Terumo Corp, Key Employee Biographies
  • Terumo Corp, Major Products and Services
  • Terumo Corp, History
  • Terumo Corp, Other Locations
  • Terumo Corp, Subsidiaries
  • Terumo Corp, Key Competitors
  • Terumo Corp, Ratios based on current share price
  • Terumo Corp, Annual Ratios
  • Terumo Corp, Interim Ratios
  • Terumo Corp, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • Terumo Corp, Medical Equipment, Deals By Type, 2020 to YTD 2026
  • Terumo Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Terumo Corp, Performance Chart (2022 - 2026)
  • Terumo Corp, Ratio Charts
  • Terumo Corp, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • Terumo Corp, Medical Equipment, Deals by Type, 2020 to YTD 2026

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Nipro Corp
  • Merit Medical Systems Inc
  • Medtronic Plc
  • JMS Co Ltd
  • Japan Lifeline Co Ltd
  • Boston Scientific Japan KK
  • Becton Dickinson and Co
  • Asahi Intecc Co Ltd